Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Neutral Rentokil Initial (RTO) by Goldman Sachs
- Neutral ASOS (ASC) by UBS
- Buy Oxford Biomedica (OXB) by Stifel
- Hold International Distributions Services (IDS) by Deutsche Bank
- Buy W.A.G Payment Solutions (WPS) by UBS
- Neutral RS Group (RS1) by UBS
- Outperform Diageo (DGE) by Bernstein
- Buy Haleon (HLN) by HSBC
- Hold Flutter Entertainment (DI) (FLTR) by HSBC
- Buy Spire Healthcare Group (SPI) by Berenberg
- Outperform Spire Healthcare Group (SPI) by RBC Capital
- Outperform Ashtead Technology Holdings (AT.) by RBC Capital
- Underweight Antofagasta (ANTO) by JP Morgan
- Overweight Rio Tinto (RIO) by JP Morgan
- Neutral SSP Group (SSPG) by UBS
- Neutral Entain (ENT) by UBS
- Buy Harbour Energy (HBR) by Jefferies
- Buy Standard Chartered (STAN) by Jefferies
- Hold Savills (SVS) by Katie Prescott in The Times - Tempus
- Buy RIT Capital Partners (RCP) by Gavin Lumsden in The Telegraph - Questor
PureTech Health (PRTC) Share Price
Health Care Sector
NOTE: This is based on 142 open tips for PureTech Health (PRTC)
| Latest Bid : 208.50p | Latest Ask : 210.00p |
| High Today : 213.00p | Low Today : 206.00p |
| This Years High : 241.50p | This Years Low : 140.40p |
| Volume : 39,511 | MKT Cap : £564.9M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
PureTech Health (PRTC) Overview
PureTech Health plc ("PureTech Health", "PureTech" or "the Company") is a clinical-stage biotherapeuticscompany dedicated to discovering, developing and commercializing highly differentiated medicines for
devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers,
lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others.
PureTech Health (PRTC) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Peel Hunt | Premium Only | 2019-11-21 12:30:00 21/11/2019 | 32.35% |
| Buy | Liberum Capital | Premium Only | 2019-11-20 11:45:00 20/11/2019 | -17.41% |
| Buy | Liberum Capital | Premium Only | 2019-11-18 14:30:00 18/11/2019 | 36.99% |
| Buy | Peel Hunt | Premium Only | 2019-11-18 10:15:00 18/11/2019 | 74.66% |
| Buy | Liberum Capital | Premium Only | 2019-11-15 11:45:00 15/11/2019 | 43.60% |
PureTech Health (PRTC) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 208.50p | Latest Ask : 210.00p |
| High Today : 213.00p | Low Today : 206.00p |
| This Years High : 241.50p | This Years Low : 140.40p |
| Volume : 39,511 | MKT Cap : £564.9M |
PureTech Health Overview
PureTech Health plc ("PureTech Health", "PureTech" or "the Company") is a clinical-stage biotherapeuticscompany dedicated to discovering, developing and commercializing highly differentiated medicines for
devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers,
lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others.
NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest PureTech Health Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Peel Hunt | Premium Only | 2019-11-21 12:30:00 21/11/2019 | 32.35% |
| Buy | Liberum Capital | Premium Only | 2019-11-20 11:45:00 20/11/2019 | -17.41% |
| Buy | Liberum Capital | Premium Only | 2019-11-18 14:30:00 18/11/2019 | 36.99% |
| Buy | Peel Hunt | Premium Only | 2019-11-18 10:15:00 18/11/2019 | 74.66% |
| Buy | Liberum Capital | Premium Only | 2019-11-15 11:45:00 15/11/2019 | 43.60% |